Harry O. Orlans

717 total citations
19 papers, 534 citations indexed

About

Harry O. Orlans is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Harry O. Orlans has authored 19 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Ophthalmology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Harry O. Orlans's work include Retinal Development and Disorders (13 papers), Retinal Diseases and Treatments (6 papers) and Photoreceptor and optogenetics research (4 papers). Harry O. Orlans is often cited by papers focused on Retinal Development and Disorders (13 papers), Retinal Diseases and Treatments (6 papers) and Photoreceptor and optogenetics research (4 papers). Harry O. Orlans collaborates with scholars based in United Kingdom, Italy and Singapore. Harry O. Orlans's co-authors include I.C.J.W. Bowler, Robert E. MacLaren, Stella Hornby, Alun R. Barnard, Maria I. Patrício, Michelle E. McClements, Nizar Din, Edward J. Casswell, Vikas Tah and Thomas L. Edwards and has published in prestigious journals such as Nature Medicine, Nature Communications and Investigative Ophthalmology & Visual Science.

In The Last Decade

Harry O. Orlans

19 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry O. Orlans United Kingdom 10 333 295 133 75 60 19 534
Karen Sophia Park United States 14 203 0.6× 421 1.4× 67 0.5× 62 0.8× 90 1.5× 23 510
Leona Serrano United States 12 257 0.8× 288 1.0× 67 0.5× 43 0.6× 32 0.5× 23 383
Tommy A. Rinkoski United States 10 222 0.7× 159 0.5× 117 0.9× 49 0.7× 24 0.4× 20 389
Yvonne K. Y. Lai Australia 7 141 0.4× 279 0.9× 92 0.7× 137 1.8× 19 0.3× 12 391
Radwan Ajlan United States 11 241 0.7× 168 0.6× 157 1.2× 24 0.3× 29 0.5× 38 401
Galuh Astuti Netherlands 12 142 0.4× 340 1.2× 42 0.3× 106 1.4× 56 0.9× 23 423
Anthony S. Halfyard United Kingdom 7 368 1.1× 342 1.2× 169 1.3× 78 1.0× 42 0.7× 9 547
Vittoria Murro Italy 14 356 1.1× 350 1.2× 154 1.2× 97 1.3× 28 0.5× 72 538
Takeshi Naito Japan 12 428 1.3× 143 0.5× 276 2.1× 31 0.4× 20 0.3× 38 576
Lucia Pelosini United Kingdom 10 299 0.9× 182 0.6× 181 1.4× 23 0.3× 15 0.3× 13 456

Countries citing papers authored by Harry O. Orlans

Since Specialization
Citations

This map shows the geographic impact of Harry O. Orlans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry O. Orlans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry O. Orlans more than expected).

Fields of papers citing papers by Harry O. Orlans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry O. Orlans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry O. Orlans. The network helps show where Harry O. Orlans may publish in the future.

Co-authorship network of co-authors of Harry O. Orlans

This figure shows the co-authorship network connecting the top 25 collaborators of Harry O. Orlans. A scholar is included among the top collaborators of Harry O. Orlans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry O. Orlans. Harry O. Orlans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Laidlaw, D A H, et al.. (2021). Using QR smartphone technology to improve patient communication and information distribution. Eye. 36(6). 1321–1322. 3 indexed citations
2.
Orlans, Harry O., Michelle E. McClements, Alun R. Barnard, Cristina Martínez-Fernández de la Cámara, & Robert E. MacLaren. (2021). Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa. Nature Communications. 12(1). 4934–4934. 28 indexed citations
3.
4.
5.
Orlans, Harry O., Alun R. Barnard, Maria I. Patrício, Michelle E. McClements, & Robert E. MacLaren. (2020). Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model. Human Gene Therapy. 31(13-14). 730–742. 15 indexed citations
6.
Orlans, Harry O., et al.. (2019). Mirtron gene therapy for the treatment of rhodopsin-related dominant retinitis pigmentosa. Investigative Ophthalmology & Visual Science. 60(9). 5195–5195. 1 indexed citations
7.
Orlans, Harry O., Alun R. Barnard, & Robert E. MacLaren. (2019). Dynamic in vivo quantification of rod photoreceptor degeneration using fluorescent reporter mouse models of retinitis pigmentosa. Experimental Eye Research. 190. 107895–107895. 5 indexed citations
8.
Orlans, Harry O., et al.. (2019). Filtration of Short-Wavelength Light Provides Therapeutic Benefit in Retinitis Pigmentosa Caused by a Common Rhodopsin Mutation. Investigative Ophthalmology & Visual Science. 60(7). 2733–2733. 11 indexed citations
9.
Gray, Joanna, Harry O. Orlans, Morag Shanks, Penny Clouston, & Robert E. MacLaren. (2018). Slowly progressive retinitis pigmentosa caused by two novel mutations in the MAK gene. Ophthalmic Genetics. 39(4). 508–511. 4 indexed citations
10.
Xue, Kanmin, Jasleen K. Jolly, Alun R. Barnard, et al.. (2018). Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. Nature Medicine. 24(10). 1507–1512. 138 indexed citations
11.
Hassall, Mark, Alun R. Barnard, Harry O. Orlans, et al.. (2018). A Novel Achromatopsia Mouse Model Resulting From a Naturally Occurring Missense Change in Cngb3. Investigative Ophthalmology & Visual Science. 59(15). 6102–6102. 5 indexed citations
12.
Orlans, Harry O., Thomas L. Edwards, Samantha R. De Silva, Maria I. Patrício, & Robert E. MacLaren. (2017). Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy. Methods in molecular biology. 1715. 289–303. 17 indexed citations
13.
Patrício, Maria I., Alun R. Barnard, Harry O. Orlans, Michelle E. McClements, & Robert E. MacLaren. (2017). Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina. Molecular Therapy — Nucleic Acids. 6. 198–208. 49 indexed citations
14.
Salvetti, Anna Paola, Maria I. Patrício, Alun R. Barnard, et al.. (2017). Impact of Vital Dyes on Cell Viability and Transduction Efficiency of AAV Vectors Used in Retinal Gene Therapy Surgery: An In Vitro and In Vivo Analysis. Translational Vision Science & Technology. 6(4). 4–4. 8 indexed citations
15.
Orlans, Harry O., et al.. (2016). Quantification of Fluorescence in Retinal Sections by Confocal Microscopy. Investigative Ophthalmology & Visual Science. 57(12). 1706–1706. 1 indexed citations
16.
Orlans, Harry O. & Fion Bremner. (2015). Dysthyroid Orbitopathy Presenting with Gaze-Evoked Amaurosis: Case Report and Review of the Literature. Orbit. 34(6). 324–326. 1 indexed citations
17.
Tah, Vikas, et al.. (2015). Anti-VEGF Therapy and the Retina: An Update. Journal of Ophthalmology. 2015. 1–13. 102 indexed citations
18.
Gupta, Ankur, Harry O. Orlans, Stella Hornby, & I.C.J.W. Bowler. (2014). Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK. Graefe s Archive for Clinical and Experimental Ophthalmology. 252(11). 1825–1830. 36 indexed citations
19.
Orlans, Harry O., Stella Hornby, & I.C.J.W. Bowler. (2011). In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye. 25(4). 489–493. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Sophia Park Breakdown of academic impact, for papers by Leona Serrano Breakdown of academic impact, for papers by Tommy A. Rinkoski Breakdown of academic impact, for papers by Yvonne K. Y. Lai Breakdown of academic impact, for papers by Radwan Ajlan Breakdown of academic impact, for papers by Galuh Astuti Breakdown of academic impact, for papers by Anthony S. Halfyard Breakdown of academic impact, for papers by Vittoria Murro Breakdown of academic impact, for papers by Takeshi Naito Breakdown of academic impact, for papers by Lucia Pelosini
Rankless by CCL
2026